Conference Material > Poster
Himanshu M, Lin Oo W, Cavalheiro AP, Mesic A, Shougrakpam J, et al.
MSF Scientific Days International 2020: Research. 2020 May 20
Journal Article > ResearchFull Text
Emerg Infect Dis. 2017 October 1; Volume 23 (Issue 10); 1711-1713.; DOI:10.3201/eid2310.170303
Achar J, Hewison CCH, Cavalheiro AP, Skrahina A, Cajazeiro J, et al.
Emerg Infect Dis. 2017 October 1; Volume 23 (Issue 10); 1711-1713.; DOI:10.3201/eid2310.170303
We describe 27 children and adolescents <18 years of age who received bedaquiline during treatment for multidrug-resistant tuberculosis. We report good treatment responses and no cessation attributable to adverse effects. Bedaquiline could be considered for use with this age group for multidrug-resistant tuberculosis when treatment options are limited.
Conference Material > Poster
Himanshu M, Lin Oo W, Cavalheiro AP, Mesic A, Shougrakpam J, et al.
MSF Scientific Days International 2020: Research. 2020 May 20